pancreatic cancer drug
Coverage of pancreatic cancer drug in the Nexus archive.
- Breakthrough pancreatic cancer drug shows survival gains that surprise experts
A novel pancreatic cancer pill nearly doubled survival time in a breakthrough trial, surprising experts. Additional health stories include advancements in flu prevention, early dementia detection methods, and a controversial drug showing rapid effects on severe depression.
- What makes promising pancreatic cancer drug different from chemotherapy?
A new drug in trials demonstrated that pancreatic cancer patients survived twice as long as those treated with chemotherapy alone. Dr. Jon LaPook reported on the findings.
- Chinese drug reduces lung cancer death risk by 34% in trial
A Chinese lung cancer drug reduced the risk of death by 34% in a late-stage trial, extending survival by four months when combined with chemotherapy for squamous non-small-cell lung cancer. The results highlight China's growing pharmaceutical innovation, alongside global advancements like Eli Lilly's obesity drug and a pancreatic cancer treatment.
- FDA expanding access to pancreatic cancer drug to some patients
The FDA announced it is expanding access to a pancreatic cancer drug that showed nearly doubled survival time for patients with advanced pancreatic cancer in a large clinical trial. This decision aims to provide earlier access to the promising treatment.